Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function

被引:153
作者
van Heek, M [1 ]
Farley, C [1 ]
Compton, DS [1 ]
Hoos, L [1 ]
Davis, HR [1 ]
机构
[1] Schering Plough Res Inst, CNS, CV Pharmacol, Kenilworth, NJ 07033 USA
关键词
cholesterol; triglyceride; fat soluble vitamins; absorption; pancreas; rat; hamster;
D O I
10.1038/sj.bjp.0704260
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Ezetimibe potently inhibits the transport of cholesterol across the intestinal wall, thereby reducing plasma cholesterol in preclinical animal models of hypercholesterolemia. The effect of ezetimibe on known absorptive processes was determined in the present studies. 2 Experiments were conducted in the hamster and/or rat to determine whether ezetimibe would affect the absorption of molecules other than free cholesterol, namely cholesteryl ester, triglyceride, ethinylestradiol, progesterone, vitamins A and D, and taurocholic acid. In addition, to determine whether exocrine pancreatic function is involved in the mechanism of action of ezetimibe, a biliary anastomosis model, which eliminates exocrine pancreatic function from the intestine while maintaining bile flow, was established in the rat. 3 Ezetimibe reduced plasma cholesterol and hepatic cholesterol accumulation in cholesterol-fed hamsters with an ED50 of 0.04 mg kg(-1). Utilizing cholesteryl esters labelled on either the cholesterol or the fatty acid moiety, we demonstrated that ezetimibe did not affect cholesteryl ester hydrolysis and the absorption of fatty acid thus generated in both hamsters and rats. The free cholesterol from this hydrolysis, however, was not absorbed (92 - 96% inhibition) in the presence of ezetimibe. Eliminating pancreatic function in rats abolished hydrolysis of cholesteryl esters, but did not affect the ability of ezetimibe to block absorption of free cholesterol (-94%). Ezetimibe did not affect the absorption of triglyceride, ethinylestradiol, progesterone, vitamins A and D, and taurocholic acid in rats. 4 Ezetimibe is a potent inhibitor of intestinal free cholesterol absorption that does not require exocrine pancreatic function for activity. Ezetimibe does not affect the absorption of triglyceride as a pancreatic lipase inhibitor (Orlistat) would, nor does it affect the absorption of vitamin A, D or taurocholate, as a bile acid sequestrant (cholestyramine) would.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 31 条
[1]  
BURRIER RE, 1995, J PHARMACOL EXP THER, V272, P156
[2]  
Davis HR, 2000, J AM COLL CARDIOL, V35, p252A
[3]  
DAVIS HR, 1995, 12 INT S DRUGS AFF L
[4]   Intestinal cholesterol absorption [J].
Dawson, PA ;
Rudel, LL .
CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (04) :315-320
[5]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[6]   Inhibition of ileal Na+ bile acid cotransporter by S-8921 reduces serum cholesterol and prevents atherosclerosis in rabbits [J].
Higaki, J ;
Hara, S ;
Takasu, N ;
Tonda, K ;
Miyata, K ;
Shike, T ;
Nagata, K ;
Mizui, T .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (08) :1304-1311
[7]  
Homan R, 1997, CURR PHARM DESIGN, V3, P29
[8]   Postprandial lipoprotein metabolism and atherosclerosis [J].
Karpe, F .
JOURNAL OF INTERNAL MEDICINE, 1999, 246 (04) :341-355
[9]  
Knopp R., 2001, ATHEROSCLEROSIS SUPP, V2, P90
[10]  
KOSOGLOU T, 2000, 3 INT C COR ART DIS, P71